Nausea is the most frequently reported side effect, occurring in 20% to 47% of clinical trial participants depending on the dose
Emerging data are studying its relationship to muscle mass and metabolic recovery in aged subjects Studied for gut microbiota changes when combined with a reduced-calorie diet
While effective in rats, this delivery method is unlikely to be practical or scalable in clinical longevity settings
Subcutaneous Protocol (4 mL = 12.5 mg/mL) Frequency: Inject once or twice daily subcutaneously
First month Judge consistency, hydration, texture, scalp comfort, application habits and whether the routine is realistic
In animal studies, BPC-157 has been reported to upregulate vascular endothelial growth factor (VEGF) and its receptor VEGFR2, which supports the formation of capillaries needed to deliver oxygen and nutrients to healing tissue